Atlas Trials

Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center

Clinical trial NCT01465360 · COMPLETED

Trial details

NCT number
NCT01465360
Sponsor
Exonhit
Status
COMPLETED
Study type
OBSERVATIONAL
Alzheimer's DiseaseMild Cognitive ImpairmentVascular DementiaFronto-temporal DementiaPrimary Progressive AphasiaParkinson' Disease DementiaMixed Dementia
Start date
2011-11-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.